Christine Scott who received C.R. Bard’s avaulta PA Biosynthetic Support System to treat urinary incontinence and pelvic organ prolapse has been awarded $3 million in compensation for injuries caused to her by the device.
The trans-vaginal surgical mesh device is designed to reinforce the vaginal wall and provide additional support to organs such as the bladder. After Surgeons implanted the mesh, Scott began retaining urine and required a catheter for nearly 6 months. Physicians determined that the mesh was too tight and performed several additional procedures to loosen it. Scott later developed pain and an infection and underwent additional surgeries to remove the mesh, but Surgeons determined that part of it had eroded into her colon and vagina and could not be removed completely. As a result, she was left with permanent faecal incontinence and chronic pain. She is also unable to have sexual intercourse and faces a risk of further infections. She may require additional surgeries in the future.
Scott sued C.R. Bard Inc. in the U.S. alleging that the Company failed to properly test the device before placing it on the market. She also alleged that Bard had failed to adequately warn Doctors of the potential risks associated with the device.
The Defence argued that the Surgeon negligently implanted the mesh too tightly which led to Scott’s urinary retention and the need for additional procedures to loosen the mesh which caused the infection and the devices erosion.
The Jury found for Scott and awarded her in excess of $3 million. There are numerous cases pending against Bard and other trans-vaginal mesh manufacturers.
If you or a loved one has suffered a similar injury you should contact Liam Moloney, Solicitor today to see how you can claim compensation.
